Search
Research outputs
MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma
[2023]
Cook, Gordon; ...; Bila, Jelena S. COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias [2024]
Spanoudakis, Michail; ...; Kapor, Suncica; ...; (broj, koautora 20)HELIOS action: Advancing research, education, and equity in haemoglobinopathies across Europe and beyond [2025]
Chatzimatthaiou, Sotiroula; Antic, Darko; ...; (broj, koautora 23)IPO-trimethylation of histone H3-lysine(9) associated with P210BCR-ABL tyrosine kinase of chronic myeloid leukaemia [2008]
Mancini, Manuela; Zuffa, Elisa; Veljković, Nevena V.DMSO causes induction of transiently transfecting rat beta(miny)(b)-globin promoter in nonerythroid cells [1996]
Mitrović, T; Pavlović, SDifferent clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura [2010]
Lotta, Luca Andrea; Mariani, Mariagabriella; Consonni, Dario; Mancini, Ilaria; Palla, Roberta; Maino, Alberto; Vucelic, Dragica AInduced synthesis of albumin-like protein in damaged rat reticulocytes [2001]
Trifunovic, A; Zaric, J; Lusic, M; Mijatovic, M; Glisin, Vladimir; Popovic, ZAn analysis of rat beta(miny)-globin gene promoter [1998]
Mitrović, T; Pavlović, SPharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follic [2013]
Davies, AJ; Merli, Francesco; Mihaljevic, Biljana SIncubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors [2000]
Ivanovic, Zoran B; Bartolozzi, B; Bernabei, PA; Cipolleschi, MG; Rovida, E; Milenkovic, Pavle B; Praloran, Vincent; Dello, Sbarba PFilters
By type
- 16